Roxadustat approved in China for the treatment of anaemia in non-dialysis-dependent patients with chronic kidney disease
AstraZeneca announced that its partner FibroGen (China) Medical Technology Development Co., Ltd. (FibroGen China) has received marketing authorisation for roxadustat in China for the...
Pfizer Invests Half Billion Dollars to Advance State-of-the-Art Gene Therapy Facility in Sanford, North Carolina
Pfizer announced an additional half billion dollar investment for the construction of its state-of-the-art gene therapy manufacturing facility in Sanford, North Carolina. This facility...
Zogenix Announces Acquisition of Modis Therapeutics, Inc.
Zogenix, Inc, a global pharmaceutical company developing rare disease therapies, announced that it has entered into a definitive agreement to acquire Modis Therapeutics, Inc.,...
Rentschler Fill Solutions receives open-ended GMP certification by the Austrian authority AGES
Rentschler Fill Solutions GmbH, a contract development and manufacturing organization (CDMO) and expert for aseptic filling and finishing of biopharmaceuticals, received notification from the...
ADC Therapeutics and Freenome Enter Biomarker Development Collaboration
ADC Therapeutics, an oncology drug discovery and development company that specializes in the development of antibody drug conjugates (ADCs), and Freenome, a biotechnology company...
Sonnet BioTherapeutics Announces Acquisition Agreement with Relief Therapeutics Holding SA for Atexakin Alpha
Sonnet BioTherapeutics, Inc., an oncology-focused biotechnology company developing innovative targeted biologic drugs, announced it has entered into an agreement with Relief Therapeutics Holding SA...
Bayer acquires BlueRock Therapeutics to build leading position in cell therapy
Bayer AG and BlueRock Therapeutics announced an agreement under which Bayer will fully acquire BlueRock Therapeutics, a privately held US-headquartered biotechnology company focused on...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...